S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CORT Corcept Therapeutics Inc

25.00

-0.06 (-0.24%)

May 03 2024 - Closed

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Corcept Therapeutics Charts.

Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Corcept Therapeutics Charts.

Corcept Therapeutics Inc News

Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
Wednesday 1 May 2024 (4 days ago) • GlobeNewswire Inc.

Corcept Completes Enrollment in Phase 4 CATALYST Trial
Monday 29 April 2024 (7 days ago) • GlobeNewswire Inc.

Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
Wednesday 24 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome
Monday 22 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)
Monday 15 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer
Monday 8 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing’s Syndrome
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

More Corcept Therapeutics Inc News Articles

Voip Pal Com (QB)

Kraig Biocraft Laborator... (QB)

Impact Fusion (PK)

Northwest Biotherapeutics (QB)

TheGlobe com (PK)

Digital Brand Media and ... (PK)

Lightwave Logic

Trump Media and Technology

Code Green Apparel (PK)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions